Key Points
- Director Ronda Stryker sold 50,000 shares at an average price of $340.10, generating $17.0 million. She continues to own 2.25 million shares, valued at approximately $765.7 million.
- Stryker reported quarterly EPS of $3.69, exceeding estimates by $0.20, while revenue rose 9.4% year over year to $6.59 billion. The company reaffirmed FY 2026 EPS guidance of $14.95–$15.10.
- The company declared a quarterly dividend of $0.88 per share, equivalent to an annualized $3.52 dividend and a 1.1% yield. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $386.28.
Stryker Corporation (NYSE:SYK - Get Free Report) Director Ronda Stryker sold 50,000 shares of the business's stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the completion of the transaction, the director directly owned 2,251,375 shares in the company, valued at $765,692,637.50. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Stryker Stock Down 3.5%
SYK stock opened at $327.97 on Friday. Stryker Corporation has a one year low of $281.00 and a one year high of $396.86. The stock has a market capitalization of $125.80 billion, a PE ratio of 33.99, a price-to-earnings-growth ratio of 2.17 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The company has a fifty day moving average of $326.64 and a 200-day moving average of $332.66.
Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. During the same quarter in the previous year, the firm earned $3.13 earnings per share. The business's quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, analysts expect that Stryker Corporation will post 15.02 EPS for the current year.
Stryker Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker's payout ratio is currently 36.48%.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on SYK shares. BTIG Research cut their target price on Stryker from $371.00 to $358.00 and set a "buy" rating for the company in a research note on Friday, July 31st. JPMorgan Chase & Co. decreased their price target on Stryker from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Friday, July 31st. Citizens Jmp cut their price objective on Stryker from $440.00 to $400.00 and set a "market outperform" rating for the company in a research report on Monday, August 3rd. Leerink Partners cut their price objective on Stryker from $410.00 to $407.00 and set an "outperform" rating for the company in a research report on Friday, June 5th. Finally, Canaccord Genuity Group reduced their target price on Stryker from $435.00 to $400.00 and set a "buy" rating for the company in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $386.28.
View Our Latest Stock Report on SYK
Institutional Investors Weigh In On Stryker
Institutional investors and hedge funds have recently modified their holdings of the company. Norges Bank acquired a new position in shares of Stryker during the 4th quarter worth $1,822,272,000. Bank of America Corp DE acquired a new stake in Stryker in the 2nd quarter valued at about $1,404,284,000. Auto Owners Insurance Co increased its holdings in Stryker by 35,047.0% during the 4th quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company's stock valued at $1,024,444,000 after acquiring an additional 2,906,448 shares in the last quarter. Legal & General Group Plc purchased a new position in Stryker during the 2nd quarter valued at about $707,212,000. Finally, Jupiter Topco LLC acquired a new position in Stryker during the second quarter worth about $681,581,000. Institutional investors and hedge funds own 77.09% of the company's stock.
About Stryker
(
Get Free Report)
Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
